Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer

Precision medicine now needs to also consider the microbiome in oncology treatment. Ingested substances, whether they are a carcinogenic or therapeutic agent, will likely come into contact with the microbiota. Even those delivered extra-intestinally can be influenced beyond xenobiotic metabolism by...

Descripción completa

Detalles Bibliográficos
Autores principales: Vareki, Saman Maleki, Chanyi, Ryan M, Abdur-Rashid, Kamilah, Brennan, Liam, Burton, Jeremy P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145517/
https://www.ncbi.nlm.nih.gov/pubmed/30263058
http://dx.doi.org/10.3332/ecancer.2018.867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145517/
https://www.ncbi.nlm.nih.gov/pubmed/30263058
http://dx.doi.org/10.3332/ecancer.2018.867

Ejemplares similares